Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishenyiqi Dripping Pills in Post-MI Chronic Heart Failure
NCT06699407Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of qishen yiqi dripping pills in chronic heart failure (CHF), sponsored by Qilu Hospital of Shandong University. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
qishen yiqi dripping pills
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT06699407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06699407.